Chorokbaem Healthcare Co Ltd (118000) - Total Liabilities
Based on the latest financial reports, Chorokbaem Healthcare Co Ltd (118000) has total liabilities worth ₩76.98 Billion KRW (≈ $52.17 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 118000 cash generation efficiency to assess how effectively this company generates cash.
Chorokbaem Healthcare Co Ltd - Total Liabilities Trend (2013–2025)
This chart illustrates how Chorokbaem Healthcare Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Chorokbaem Healthcare Co Ltd (118000) asset resilience to evaluate the company's liquid asset resilience ratio.
Chorokbaem Healthcare Co Ltd Competitors by Total Liabilities
The table below lists competitors of Chorokbaem Healthcare Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
GoldMining Inc
TO:GOLD
|
Canada | CA$8.36 Million |
|
LAVIPHARM S.A. NA EO 1
F:BXA0
|
Germany | €72.52 Million |
|
Daehan Steel
KO:084010
|
Korea | ₩311.32 Billion |
|
Cogelec SA
PA:ALLEC
|
France | €95.77 Million |
|
Silver Storm Mining Ltd.
V:SVRS
|
Canada | CA$13.18 Million |
|
Mitrabahtera Segara Sejati Tbk
JK:MBSS
|
Indonesia | Rp23.93 Million |
|
Vine Hill Capital Investment Corp. Class A Ordinary Shares
NASDAQ:VCIC
|
USA | $234.54 Million |
|
Roman DBDR Acquisition Corp. II Ordinary shares
NASDAQ:DRDB
|
USA | $1.10 Million |
Liability Composition Analysis (2013–2025)
This chart breaks down Chorokbaem Healthcare Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Chorokbaem Healthcare Co Ltd worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.56 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.64 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Chorokbaem Healthcare Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Chorokbaem Healthcare Co Ltd (2013–2025)
The table below shows the annual total liabilities of Chorokbaem Healthcare Co Ltd from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩76.98 Billion ≈ $52.17 Million |
+87.67% |
| 2024-12-31 | ₩41.02 Billion ≈ $27.80 Million |
+133.08% |
| 2023-12-31 | ₩17.60 Billion ≈ $11.93 Million |
-70.80% |
| 2022-12-31 | ₩60.28 Billion ≈ $40.85 Million |
+5.93% |
| 2021-12-31 | ₩56.90 Billion ≈ $38.56 Million |
-8.47% |
| 2020-12-31 | ₩62.17 Billion ≈ $42.13 Million |
+83.55% |
| 2019-12-31 | ₩33.87 Billion ≈ $22.95 Million |
-21.10% |
| 2018-12-31 | ₩42.93 Billion ≈ $29.09 Million |
+138.07% |
| 2017-12-31 | ₩18.03 Billion ≈ $12.22 Million |
+17.03% |
| 2016-12-31 | ₩15.41 Billion ≈ $10.44 Million |
+50.77% |
| 2015-12-31 | ₩10.22 Billion ≈ $6.93 Million |
-10.02% |
| 2014-12-31 | ₩11.36 Billion ≈ $7.70 Million |
+91.74% |
| 2013-12-31 | ₩5.92 Billion ≈ $4.01 Million |
-- |
About Chorokbaem Healthcare Co Ltd
METACARE CO., Ltd. distributes pharmaceuticals and medical devices in South Korea. The company sells orthopedic medical devices and consumables; and provides pharmaceutical integration and professional logistics services. It is involved in investment advisory. The company was formerly known as SMEDI Co., Ltd. and changed its name to METACARE CO., Ltd. in August 2024. METACARE CO., Ltd. was founde… Read more